Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Blood Cancer Journal|April 1, 2026
Effectiveness of linvoseltamab versus real-world standard-of-care in triple-class-exposed relapsed/refractory multiple myeloma in the United StatesShaji Kumar, Katja C Weisel, Paul Spin, et al.
Allergy|May 15, 2026
Type-2-Inflammatory-Diseases Share Comorbidities, Molecular Signatures, IL4/IL13 Genetics, and Response to IL4/IL13 BlockadeJennifer D Hamilton, Manuel A R Ferreira, Wei Keat Lim, et al.
Breast Cancer Research : BCR|March 21, 2019
Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail modelTess V Clendenen, Wenzhen Ge, Karen L Koenig, et al.
International Journal of Cancer|January 10, 2018
Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohortsWenzhen Ge, Tess V Clendenen, Yelena Afanasyeva, et al.
The Journal of Clinical Endocrinology and Metabolism|June 22, 2021
Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal WomenTess V Clendenen, Wenzhen Ge, Karen L Koenig, et al.
Blood Cancer Journal|March 26, 2026
Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myelomaShaji Kumar, Sundar Jagannath, Katja C Weisel, et al.
BMJ (Clinical Research Ed.)|January 30, 2014
Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort ConsortiumYu Chen, Wade K Copeland, Rajesh Vedanthan, et al.
Pageof 4